Alyson R Plecash1, Amokrane Chebini1, Alvin Ip2, Joshua J Lai1, Andrew A Mattar1, Jason Randhawa1, Thalia S Field3,4. 1. Division of Neurology, Faculty of Medicine, University of British Columbia, S169-2211 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada. 2. Division of Physical Medicine and Rehabilitation, University of British Columbia, Vancouver, BC, Canada. 3. Division of Neurology, Faculty of Medicine, University of British Columbia, S169-2211 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada. thalia.field@ubc.ca. 4. Vancouver Stroke Program, Vancouver Coastal Health, Vancouver, BC, Canada. thalia.field@ubc.ca.
Abstract
PURPOSE OF REVIEW: To provide an overview of the current treatment strategies for common subtypes of post-stroke pain. RECENT FINDINGS: There is growing research interest in non-pharmacological treatment approaches for chronic pain, including neurostimulation as well as lifestyle and psychosocial interventions. Newer pharmacotherapy research includes cannabinoids and NMDA-receptor antagonists as well as bee venom. Persistent post-stroke headache is an increasingly appreciated entity, though the role of novel chronic migraine treatments for post-stroke headache is not known. Overall, most treatment approaches to post-stroke pain lack high-quality evidence. Stroke survivors are in need of effective treatments based on methodologically sound evidence. To address the interplay of clinical and psychosocial factors that contribute to post-stroke pain, it may be reasonable to adopt a multimodal treatment strategy incorporating both lifestyle interventions and conventional therapies.
PURPOSE OF REVIEW: To provide an overview of the current treatment strategies for common subtypes of post-stroke pain. RECENT FINDINGS: There is growing research interest in non-pharmacological treatment approaches for chronic pain, including neurostimulation as well as lifestyle and psychosocial interventions. Newer pharmacotherapy research includes cannabinoids and NMDA-receptor antagonists as well as bee venom. Persistent post-stroke headache is an increasingly appreciated entity, though the role of novel chronic migraine treatments for post-stroke headache is not known. Overall, most treatment approaches to post-stroke pain lack high-quality evidence. Stroke survivors are in need of effective treatments based on methodologically sound evidence. To address the interplay of clinical and psychosocial factors that contribute to post-stroke pain, it may be reasonable to adopt a multimodal treatment strategy incorporating both lifestyle interventions and conventional therapies.
Authors: Jörg Wissel; Ludwig D Schelosky; Jeffrey Scott; Walter Christe; Jürgen H Faiss; Jörg Mueller Journal: J Neurol Date: 2010-02-06 Impact factor: 4.849
Authors: Carolee J Winstein; Joel Stein; Ross Arena; Barbara Bates; Leora R Cherney; Steven C Cramer; Frank Deruyter; Janice J Eng; Beth Fisher; Richard L Harvey; Catherine E Lang; Marilyn MacKay-Lyons; Kenneth J Ottenbacher; Sue Pugh; Mathew J Reeves; Lorie G Richards; William Stiers; Richard D Zorowitz Journal: Stroke Date: 2016-05-04 Impact factor: 7.914
Authors: Michael Creamer; Geoffrey Cloud; Peter Kossmehl; Michael Yochelson; Gerard E Francisco; Anthony B Ward; Jörg Wissel; Mauro Zampolini; Abdallah Abouihia; Alessandra Calabrese; Leopold Saltuari Journal: Stroke Date: 2018-09 Impact factor: 7.914
Authors: Carlo Trompetto; Lucio Marinelli; Laura Mori; Luca Puce; Chiara Avanti; Elena Saretti; Giulia Biasotti; Roberta Amella; Filippo Cotellessa; Domenico A Restivo; Antonio Currà Journal: Toxins (Basel) Date: 2022-01-05 Impact factor: 4.546